Character sizeLargeSmall

WHO Goodwill Ambassador's Newsletter For The Elimination Of Leprosy

NEWS: New Foundation Established in India

Delhi-based NGO to promote economic advancement, social reintegration

Yohei Sasakawa presents SILF Executive
Director Dr. Vineeta Shanker with the
cheque he received for winning the
International Gandhi Award.

The Sasakawa-India Leprosy Foundation (SILF) has been established in New Delhi, India.
The new public charity, an initiative of Goodwill Ambassador Yohei Sasakawa, will work to facilitate the empowerment and economic advancement of people affected by leprosy and their families and promote their integration into mainstream society.
The official launch of SILF is scheduled for October 2007.

An informal consultation was held in India late last year to look at rifampicin resistance in the treatment of leprosy. Rifampicin is a core component of multidrug therapy, which has been key to the dramatic decline in the prevalence of the disease over the past two decades.
Organized by the WHO, the meeting concluded that surveillance of rifampicin resistance should be established immediately to ensure that the success of the MDT program is not threatened.